info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Organ-on-a-chip Market Research Report Information By Organ Type (Lung-on-Chip, Heart-on-Chip, Liver-on-Chip, Intestine-on-Chip, Kidney-on-Chip, Human-on-Chip), By Application (Drug Discovery, Toxicology Research, Others) and By End-User (Pharmaceutical Companies, Research Organizations, Others) – Forecast to 2032


ID: MRFR/HC/7026-HCR | 120 Pages | Author: Rahul Gotadki| November 2024

Research Methodology on Organ on Chip Market


Introduction


Organ-on-Chip (OoC) technology is an innovative technology that is revolutionizing the biomedical research field. It involves the creation of miniature lab-on-chip systems containing living cells, micro-channels, sensors, actuators and other related components. It has enabled researchers to bypass the traditional bottlenecks associated with animal studies, enabling them to develop more effective drugs that have a higher rate of success and faster results than conventional drug development studies. This technology has also enabled researchers to simulate more complex human physiology more accurately, which in turn has allowed the development of personalized medicines and treatments.


The purpose of this research project is to understand the current market size of the Organ-on-Chip technology, identify the key products in the market, determine the future growth of the technology, and assess the market potential of the technology.


Research Objectives



  • To analyze the market size of the Organ-on-Chip technology.

  • To identify key players in the Organ-on-Chip technology market.

  • To understand the growth potential of the technology.

  • To identify threats and opportunities in the Organ-on-Chip technology market.


Research Questions



  • What is the current market size of the Organ-on-Chip technology?

  • Who are the leading players in the Organ-on-Chip technology market?

  • What is the growth potential of Organ-on-Chip technology?

  • What are the threats and opportunities in the Organ-on-Chip technology market?


Research Approach


This research will employ descriptive, as well as exploratory research approaches in order to gain an in-depth understanding of the Organ-on-Chip technology market. Descriptive research is used to analyze the size and scope of the current Organ-on-Chip technology market and identify the key players in the industry. Exploratory research is employed to gain a better understanding of the growth potential of the technology, as well as identify the threats and opportunities present in the market.


Research Design


The research employs both qualitative and quantitative research designs. The qualitative design involves semi-structured interviews with key industry experts and stakeholders, as well as analyzing secondary sources including reports, industry white papers, and other available data. The quantitative design involves surveys and polls, as well as analysis of the data, gathered through qualitative research.


Sampling & Data Collection


The sample size for the research will be 1000 respondents, strategically chosen to provide a comprehensive overview of the Organ-on-Chip technology market. The sample includes representatives from key sectors of the industry, such as manufacturers of technology, agricultural and pharmaceutical companies, research institutions, government agencies, as well as other stakeholders. The data is collected using both primary and secondary methods. Primary methods include surveys and face-to-face interviews, while secondary methods involve analysis of available published documents, industry reports, and other available data.


Data Analysis


The collected data is analyzed using both quantitative and qualitative methods. Quantitative data analysis tools such as SPSS and Excel are utilized to analyze the collected data statistically and to generate results from the surveys and polls. Qualitative data analysis methods, such as content analysis and thematic analysis, are used to analyze the interviews conducted with experts and stakeholders.


Conclusion


The organ-on-chip technology market has enormous potential and could revolutionize the research and drug development sector. This research provides an in-depth understanding of the current market size and scope, the key players in the industry, the potential growth of the technology, as well as the threats and opportunities present in the market. The findings of this research prove to be beneficial for key stakeholders in the industry.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

Table of Contents

1. REPORT PROLOGUE

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

6. GLOBAL ORGAN-ON-A-CHIP MARKET, BY ORGAN TYPE

6.1. Overview

6.2. Lung-on-Chip

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3. Heart-on-Chip

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4. Liver-on-Chip

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.5. Intestine-on-Chip

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.6. Kidney-on-Chip

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.7. Skin-on-Chip

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.8. Blood-Brain Barrier-on-Chip

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.9. Human-on-Chip

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.10. Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7. GLOBAL ORGAN-ON-A-CHIP MARKET, BY APPLICATION

7.1. Overview

7.2. Drug Discovery

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3. Toxicology Research

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4. Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8. GLOBAL ORGAN-ON-A-CHIP MARKET, BY ENDUSER

8.1. Overview

8.2. Pharmaceutical Companies

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3. Research Organizations

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4. Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9. GLOBAL ORGAN-ON-A-CHIP MARKET, BY REGION

9.1. Overview

9.2. Americas

9.2.1. North America

9.2.1.1. US

9.2.1.2. Canada

9.2.2. Latin America

9.3. Europe

9.3.1. Western Europe

9.3.1.1. Germany

9.3.1.2. France

9.3.1.3. Italy

9.3.1.4. Spain

9.3.1.5. UK

9.3.1.6. Rest of Western Europe

9.3.2. Eastern Europe

9.4. Asia-Pacific

9.4.1. Japan

9.4.2. China

9.4.3. India

9.4.4. Australia

9.4.5. South Korea

9.4.6. Rest of Asia-Pacific

9.5. Middle East & Africa

9.5.1. Middle East

9.5.2. Africa

10. COMPANY LANDSCAPE

10.1. Overview

10.2. Competitive Analysis

10.3. Market Share Analysis

10.4. Major Growth Strategy in the Global Organ-on-a-Chip Market

10.5. Competitive Benchmarking

10.6. Leading Players in terms of Number of Developments in the Global Organ-on-a-Chip Market

10.7. Key Developments and Growth Strategies

10.7.1. Product Launch

10.7.2. Merger & Acquisitions

10.7.3. Joint Ventures

10.8. Major Players Financial Matrix & Market Ratio

10.8.1. Sales & Operating Income 2020

10.8.2. Major Players R&D Expenditure 2020

10.9. Major Players Capital Market Ratio

11. COMPANY PROFILES

11.1. CN Bio Innovations Limited

11.1.1. Company Overview

11.1.2. Financial Overview

11.1.3. Product Offered

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. Emulate

11.2.1. Company Overview

11.2.2. Financial Overview

11.2.3. Product Offered

11.2.4. Key Developments

11.2.5. SWOT Analysis

11.2.6. Key Strategies

11.3. TissUse

11.3.1. Company Overview

11.3.2. Financial Overview

11.3.3. Product Offered

11.3.4. Key Developments

11.3.5. SWOT Analysis

11.3.6. Key Strategies

11.4. Mimetas

11.4.1. Company Overview

11.4.2. Financial Overview

11.4.3. Product Offered

11.4.4. Key Developments

11.4.5. SWOT Analysis

11.4.6. Key Strategies

11.5. Hµrel

11.5.1. Company Overview

11.5.2. Financial Overview

11.5.3. Product Offered

11.5.4. Key Developments

11.5.5. SWOT Analysis

11.5.6. Key Strategies

11.6. Nortis

11.6.1. Company Overview

11.6.2. Financial Overview

11.6.3. Product Offered

11.6.4. Key Developments

11.6.5. SWOT Analysis

11.6.6. Key Strategies

11.7. Insphero

11.7.1. Company Overview

11.7.2. Financial Overview

11.7.3. Product Offered

11.7.4. Key Developments

11.7.5. SWOT Analysis

11.7.6. Key Strategies

11.8. Tara Biosystems

11.8.1. Company Overview

11.8.2. Financial Overview

11.8.3. Product Offered

11.8.4. Key Developments

11.8.5. SWOT Analysis

11.8.6. Key Strategies

11.9. AxoSim Technologies LLC

11.9.1. Company Overview

11.9.2. Financial Overview

11.9.3. Product Offered

11.9.4. Key Developments

11.9.5. SWOT Analysis

11.9.6. Key Strategies

11.10. Organovo

11.10.1. Company Overview

11.10.2. Financial Overview

11.10.3. Product Offered

11.10.4. Key Developments

11.10.5. SWOT Analysis

11.10.6. Key Strategies

11.11. BioIVT

11.11.1. Company Overview

11.11.2. Financial Overview

11.11.3. Product Offered

11.11.4. Key Developments

11.11.5. SWOT Analysis

11.11.6. Key Strategies

11.12. HemoShear

11.12.1. Company Overview

11.12.2. Financial Overview

11.12.3. Product Offered

11.12.4. Key Developments

11.12.5. SWOT Analysis

11.12.6. Key Strategies

12. APPENDIX

12.1. References

12.2. Related Reports 

LIST OF TABLES

TABLE 1 GLOBAL ORGAN-ON-A-CHIP MARKET SYNOPSIS, 2020-2027

TABLE 2 GLOBAL ORGAN-ON-A-CHIP MARKET ESTIMATES & FORECAST, 2020-2027 (USD MILLION)

TABLE 3 GLOBAL ORGAN-ON-A-CHIP MARKET, BY ORGAN TYPE, 2020-2027 (USD MILLION)

TABLE 4 GLOBAL ORGAN-ON-A-CHIP MARKET, BY APPLICATION, 2020-2027 (USD MILLION)

TABLE 5 GLOBAL ORGAN-ON-A-CHIP MARKET, BY ENDUSER, 2020-2027 (USD MILLION)

TABLE 6 GLOBAL ORGAN-ON-A-CHIP MARKET, BY REGION, 2020-2027 (USD MILLION)

TABLE 7 NORTH AMERICA: ORGAN-ON-A-CHIP MARKET, BY ORGAN TYPE, 2020-2027 (USD MILLION)

TABLE 8 NORTH AMERICA: ORGAN-ON-A-CHIP MARKET, BY APPLICATION, 2020-2027 (USD MILLION)

TABLE 9 NORTH AMERICA: ORGAN-ON-A-CHIP MARKET, BY ENDUSER, 2020-2027 (USD MILLION)

TABLE 10 US: ORGAN-ON-A-CHIP MARKET, BY ORGAN TYPE, 2020-2027 (USD MILLION)

TABLE 11 US: ORGAN-ON-A-CHIP MARKET, BY APPLICATION, 2020-2027 (USD MILLION)

TABLE 12 US: ORGAN-ON-A-CHIP MARKET, BY ENDUSER, 2020-2027 (USD MILLION)

TABLE 13 CANADA: ORGAN-ON-A-CHIP MARKET, BY ORGAN TYPE, 2020-2027 (USD MILLION)

TABLE 14 CANADA: ORGAN-ON-A-CHIP MARKET, BY APPLICATION, 2020-2027 (USD MILLION)

TABLE 15 CANADA: ORGAN-ON-A-CHIP MARKET, BY ENDUSER, 2020-2027 (USD MILLION)

TABLE 16 LATIN AMERICA: ORGAN-ON-A-CHIP MARKET, BY ORGAN TYPE, 2020-2027 (USD MILLION)

TABLE 17 LATIN AMERICA: ORGAN-ON-A-CHIP MARKET, BY APPLICATION, 2020-2027 (USD MILLION)

TABLE 18 LATIN AMERICA: ORGAN-ON-A-CHIP MARKET, BY ENDUSER, 2020-2027 (USD MILLION)

TABLE 19 EUROPE: ORGAN-ON-A-CHIP MARKET, BY ORGAN TYPE, 2020-2027 (USD MILLION)

TABLE 20 EUROPE: ORGAN-ON-A-CHIP MARKET, BY APPLICATION, 2020-2027 (USD MILLION)

TABLE 21 EUROPE: ORGAN-ON-A-CHIP MARKET, BY ENDUSER, 2020-2027 (USD MILLION)

TABLE 22 WESTERN EUROPE: ORGAN-ON-A-CHIP MARKET, BY ORGAN TYPE, 2020-2027 (USD MILLION)

TABLE 23 WESTERN EUROPE: ORGAN-ON-A-CHIP MARKET, BY APPLICATION, 2020-2027 (USD MILLION)

TABLE 24 WESTERN EUROPE: ORGAN-ON-A-CHIP MARKET, BY ENDUSER, 2020-2027 (USD MILLION)

TABLE 25 EASTERN EUROPE: ORGAN-ON-A-CHIP MARKET, BY ORGAN TYPE, 2020-2027 (USD MILLION)

TABLE 26 EASTERN EUROPE: ORGAN-ON-A-CHIP MARKET, BY APPLICATION, 2020-2027 (USD MILLION)

TABLE 27 EASTERN EUROPE: ORGAN-ON-A-CHIP MARKET, BY ENDUSER, 2020-2027 (USD MILLION)

TABLE 28 ASIA-PACIFIC: ORGAN-ON-A-CHIP MARKET, BY ORGAN TYPE, 2020-2027 (USD MILLION)

TABLE 29 ASIA-PACIFIC: ORGAN-ON-A-CHIP MARKET, BY APPLICATION, 2020-2027 (USD MILLION)

TABLE 30 ASIA-PACIFIC: ORGAN-ON-A-CHIP MARKET, BY ENDUSER, 2020-2027 (USD MILLION)

TABLE 31 MIDDLE EAST & AFRICA: ORGAN-ON-A-CHIP MARKET, BY ORGAN TYPE, 2020-2027 (USD MILLION)

TABLE 32 MIDDLE EAST & AFRICA: ORGAN-ON-A-CHIP MARKET, BY APPLICATION, 2020-2027 (USD MILLION)

TABLE 33 MIDDLE EAST & AFRICA: ORGAN-ON-A-CHIP MARKET, BY ENDUSER, 2020-2027 (USD MILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL ORGAN-ON-A-CHIP MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL ORGAN-ON-A-CHIP MARKET

FIGURE 4 GLOBAL ORGAN-ON-A-CHIP MARKET SHARE, BY ORGAN TYPE, 2020 (%)

FIGURE 5 GLOBAL ORGAN-ON-A-CHIP MARKET SHARE, BY APPLICATION, 2020 (%)

FIGURE 6 GLOBAL ORGAN-ON-A-CHIP MARKET SHARE BY ENDUSER,2020 (%)

FIGURE 6 GLOBAL ORGAN-ON-A-CHIP MARKET SHARE, BY REGION, 2020 (%)

FIGURE 7 AMERICAS: ORGAN-ON-A-CHIP MARKET SHARE BY REGION, 2020 (%)

FIGURE 7 NORTH AMERICA: ORGAN-ON-A-CHIP MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 8 EUROPE: ORGAN-ON-A-CHIP MARKET SHARE, BY REGION, 2020 (%)

FIGURE 9 WESTERN EUROPE: ORGAN-ON-A-CHIP MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 10 ASIA-PACIFIC: ORGAN-ON-A-CHIP MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 11 MIDDLE EAST & AFRICA: ORGAN-ON-A-CHIP MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 12 GLOBAL ORGAN-ON-A-CHIP MARKET: COMPANY SHARE ANALYSIS, 2020 (%)

FIGURE 13 CN BIO INNOVATIONS LIMITED.: KEY FINANCIALS

FIGURE 14 CN BIO INNOVATIONS LIMITED: SEGMENTAL REVENUE

FIGURE 15 CN BIO INNOVATIONS LIMITED: REGIONAL REVENUE

FIGURE 16 EMULATE: KEY FINANCIALS

FIGURE 17 EMULATE: SEGMENTAL REVENUE

FIGURE 18 EMULATE: REGIONAL REVENUE

FIGURE 19 TISSUSE: KEY FINANCIALS

FIGURE 20 TISSUSE: SEGMENTAL REVENUE

FIGURE 21 TISSUSE: REGIONAL REVENUE

FIGURE 22 MIMETAS: KEY FINANCIALS

FIGURE 23 MIMETAS: SEGMENTAL REVENUE

FIGURE 24 MIMETAS: REGIONAL REVENUE

FIGURE 25 HµREL: KEY FINANCIALS

FIGURE 26 HµREL: SEGMENTAL REVENUE

FIGURE 27 HµREL: REGIONAL REVENUE

FIGURE 28 NORTIS: KEY FINANCIALS

FIGURE 29 NORTIS: SEGMENTAL REVENUE

FIGURE 30 NORTIS: REGIONAL REVENUE

FIGURE 31 TARA BIOSYSTEMS: KEY FINANCIALS

FIGURE 32 TARA BIOSYSTEMS: SEGMENTAL REVENUE

FIGURE 33 TARA BIOSYSTEMS: REGIONAL REVENUE

FIGURE 34 INSPHERO: KEY FINANCIALS

FIGURE 35 INSPHERO: SEGMENTAL REVENUE

FIGURE 36 INSPHERO: REGIONAL REVENUE

FIGURE 37 AXOSIM TECHNOLOGIES LLC: KEY FINANCIALS

FIGURE 38 AXOSIM TECHNOLOGIES LLC: SEGMENTAL REVENUE

FIGURE 39 AXOSIM TECHNOLOGIES LLC: REGIONAL REVENUE

FIGURE 40 ASCENDANCE: KEY FINANCIALS

FIGURE 41 ASCENDANCE: SEGMENTAL REVENUE

FIGURE 42 ASCENDANCE: REGIONAL REVENUE

FIGURE 43 HEMOSHEAR: KEY FINANCIALS

FIGURE 44 HEMOSHEAR: SEGMENTAL REVENUE

FIGURE 45 HEMOSHEAR: REGIONAL REVENUE

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.